These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 1586586)

  • 21. Synthesis and biological activities of the optical isomers of (+/-)-4-amino-5-chloro-2-ethoxy-N-[[4-(4-fluorobenzyl)-2- morpholinyl]methyl]benzamide (mosapride).
    Morie T; Kato S; Harada H; Yoshida N; Matsumoto J
    Chem Pharm Bull (Tokyo); 1994 Apr; 42(4):877-82. PubMed ID: 8020122
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stereoisomers of N-substituted soft anticholinergics and their zwitterionic metabolite based on glycopyrrolate--syntheses and pharmacological evaluations.
    Wu WM; Wu J; Mori N; Buchwald P; Bodor N
    Pharmazie; 2008 Mar; 63(3):200-9. PubMed ID: 18444508
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Absolute configuration and biological activity of mequitamium iodide enantiomers.
    Di Bugno C; Dapporto P; Giorgi R; Manzini S; Paoli P; Subissi A; Arcamone F
    Chirality; 1994; 6(5):382-8. PubMed ID: 8068497
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacological properties of the receptor(s) involved in the 5-hydroxytryptamine-induced contraction of the feline middle cerebral artery.
    Hamel E; Robert JP; Young AR; MacKenzie ET
    J Pharmacol Exp Ther; 1989 Jun; 249(3):879-89. PubMed ID: 2732950
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New esters of 4-amino-5-chloro-2-methoxybenzoic acid as potent agonists and antagonists for 5-HT4 receptors.
    Yang D; Soulier JL; Sicsic S; Mathé-Allainmat M; Brémont B; Croci T; Cardamone R; Aureggi G; Langlois M
    J Med Chem; 1997 Feb; 40(4):608-21. PubMed ID: 9046352
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SC-49518 enhances gastric emptying of solid and liquid meals and stimulates gastrointestinal motility in dogs by a 5-hydroxytryptamine4 receptor mechanism.
    Gullikson GW; Virina MA; Loeffler RF; Yang DC; Goldstin B; Wang SX; Moummi C; Flynn DL; Zabrowski DL
    J Pharmacol Exp Ther; 1993 Jan; 264(1):240-8. PubMed ID: 8380862
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacological properties of quinoxaline derivatives as a new class of 5-HT3 receptor antagonists.
    Lasheras B; Berjón A; Montañés R; Roca J; Romero G; Ramírez MJ; Del Río J
    Arzneimittelforschung; 1996 Apr; 46(4):401-6. PubMed ID: 8740088
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification and distribution of 5-HT3 receptors in rat brain using radioligand binding.
    Kilpatrick GJ; Jones BJ; Tyers MB
    Nature; 1987 Dec 24-31; 330(6150):746-8. PubMed ID: 3696238
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Studies on the pharmacology of the novel histamine H3 receptor agonist Sch 50971.
    Hey JA; Aslanian R; Bolser DC; Chapman RW; Egan RW; Rizzo CA; Shih NY; Fernandez X; McLeod RL; West R; Kreutner W
    Arzneimittelforschung; 1998 Sep; 48(9):881-8. PubMed ID: 9793613
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cisapride and 5-hydroxytryptamine enhance motility in the canine antrum via separate pathways, not involving 5-hydroxytryptamine1,2,3,4 receptors.
    de Ridder WJ; Schuurkes JA
    J Pharmacol Exp Ther; 1993 Jan; 264(1):79-88. PubMed ID: 8093733
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Pharmacologic properties of ortho-ethoxy-benzamide].
    Legheand J; Boiron J; Cier A
    Ann Pharm Fr; 1977; 35(9-10):387-98. PubMed ID: 305744
    [No Abstract]   [Full Text] [Related]  

  • 32. Comparison of the potencies of clebopride and other substituted benzamide drugs on isolated gastrointestinal tract of the guinea-pig and rat.
    Masso JL; Roberts DJ
    J Pharm Pharmacol; 1980 Oct; 32(10):727-8. PubMed ID: 6107356
    [No Abstract]   [Full Text] [Related]  

  • 33. Synthesis and pharmacological activity of 4-amino-5-chloro-2-methoxy-N-[(2S,4S)-1-ethyl-2-hydroxymethyl-4- pyrrolidinyl]benzamide (TKS159) and its optical isomers.
    Yanagi T; Kitajima A; Anzai K; Kodama K; Mizoguchi J; Fujiwara H; Sakiyama H; Kamoda O; Kamei C
    Chem Pharm Bull (Tokyo); 1999 Nov; 47(11):1650-4. PubMed ID: 10605060
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sex-differences in the disposition of substituted benzamides: pharmacokinetics of a gastroprokinetic agent (4-amino-5-chloro-2-[2- (methylsulfinyl) ethoxy]-N-[2-(diethylamino)ethyl] benzamide hydrochloride) (ML-1035) in male and female New Zealand white rabbits.
    Rao N; Otis KW; Hwang KK
    Biopharm Drug Dispos; 1992 Dec; 13(9):681-91. PubMed ID: 1467455
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis and biological activities of metabolites of mosapride, a new gastroprokinetic agent.
    Kato S; Morie T; Yoshida N
    Chem Pharm Bull (Tokyo); 1995 Apr; 43(4):699-702. PubMed ID: 7600620
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics and metabolic interconversion of intravenous 4-amino-5-chloro-2-[(methylsulfinyl)ethoxy]-N-[2-(diethylamino)ethyl] benzamide and its sulfide and sulfone metabolites in rats.
    Kuo BS; Poole JC; Hwang KK; Cheng H
    J Pharm Sci; 1993 Jul; 82(7):694-8. PubMed ID: 8360842
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serotonin 5-HT4 receptor agonistic activity of the optical isomers of (+/-)-4-amino-N-[2-(1-azabicyclo[3.3.0]octan-5-yl)ethyl]-5-chloro-2,3- dihydro-2-methylbenzo[b]furan-7-carboxamide.
    Kakigami T; Usui T; Ikami T; Tsukamoto K; Miwa Y; Taga T; Kataoka T
    Chem Pharm Bull (Tokyo); 1998 Jun; 46(6):1039-43. PubMed ID: 9658578
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Resolution, absolute configuration, and cholinergic enantioselectivity of (-)- and (+)-c-2-methyl-r-5-[(dimethylamino)methyl]-1,3-oxathiolane t-3-oxide methiodide and related sulfones.
    Teodori E; Gualtieri F; Angeli P; Brasili L; Giannella M
    J Med Chem; 1987 Oct; 30(10):1934-8. PubMed ID: 3656366
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Determination of bioavailability and systemically available fractions of drugs undergoing reversible metabolism: application to 4-amino-5-chloro-2-[2-(methylsulfinyl)ethoxy]-N-[2- (diethylamino)ethyl]benzamide and its sulfide and sulfone metabolites in rats.
    Kuo BS; Poole JC; Hwang KK; Cheng H
    J Pharm Sci; 1994 Mar; 83(3):386-90. PubMed ID: 8207687
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Method for optical resolution of racemic homochlorcyclizine and comparison of optical isomers in antihistamine activity and pharmacokinetics.
    Nishikata M; Nakai A; Fushida H; Miyake K; Arita T; Kitagawa S; Kunitomo M; Iseki K; Miyazaki K
    Chem Pharm Bull (Tokyo); 1992 May; 40(5):1341-2. PubMed ID: 1356640
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.